CENTURY THERAPEUTICS INC (IPSC:NASDAQ)
$2.3 -0.04 (-1.7094%)
Analysed CENTURY THERAPEUTICS INC (IPSC:NASDAQ) News Sources
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
12-03-2026
yahoo.com
Century Therapeutics to Participate in Upcoming Investor Conferences in March
25-02-2026
yahoo.com
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission
30-01-2026
yahoo.com
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
22-01-2026
yahoo.com
Promising Penny Stocks To Watch In January 2026
16-01-2026
yahoo.com
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
08-01-2026
yahoo.com
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
07-01-2026
yahoo.com
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
07-01-2026
yahoo.com
3 Promising Penny Stocks With Market Caps Over $30M
18-12-2025
yahoo.com
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
09-12-2025
yahoo.com
What is the current price of CENTURY THERAPEUTICS INC (IPSC:NASDAQ)?
The current price of CENTURY THERAPEUTICS INC (IPSC:NASDAQ) is $2.3.
CENTURY THERAPEUTICS INC (IPSC:NASDAQ) absolute price change since previous trading day?
The absolute price change of CENTURY THERAPEUTICS INC (IPSC:NASDAQ) since the previous trading day is $-0.04.
CENTURY THERAPEUTICS INC (IPSC:NASDAQ) percentage price change since previous trading day?
The percentage price change of CENTURY THERAPEUTICS INC (IPSC:NASDAQ) since the previous trading day is -1.7094%.
What is the most recent average sentiment score for CENTURY THERAPEUTICS INC (IPSC:NASDAQ)?
The most recent average sentiment score for CENTURY THERAPEUTICS INC (IPSC:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for CENTURY THERAPEUTICS INC (IPSC:NASDAQ)?
The most recent sentiment for CENTURY THERAPEUTICS INC (IPSC:NASDAQ) is .
SEC-8K** Filing Available For CENTURY THERAPEUTICS INC (IPSC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.